Overview

Curcumin-Simvastatin-EDTA in the Treatment of Periodontitis

Status:
Completed
Trial end date:
2018-10-03
Target enrollment:
0
Participant gender:
All
Summary
Among the root conditioning materials is the Ethylenediaminetetraacetic acid (EDTA). EDTA exposes the collagen fibers on dentin surfaces and also enhances early cell colonization. Statins have an anti-inflammatory effect, inhibit the bone resorption and stimulate the bone formation. Curcumin is effective in preventing periodontal disease destruction by targeting both bacteria and host inflammatory cells. Curcumin has anti- inflammatory, antioxidant, anticarcinogenic, antiviral, and antimicrobial functions. This study will be carried out to examine the effect of simvastatin-curcumin paste following EDTA root surface etching when used in conjunction with open flap debridement treating deep periodontal pockets (suggesting that it may have positive effect)
Phase:
Phase 4
Accepts Healthy Volunteers?
Accepts Healthy Volunteers
Details
Lead Sponsor:
Ain Shams University
Treatments:
Curcumin
Edetic Acid
Simvastatin
Criteria
Inclusion Criteria:

- Patient suffering at least a single posterior 2-3 wall periodontal Pocket of depth ≥ 5
mm, attachment loss ≥3 mm, intrabony component ≥3 mm, plaque index ≤1 (Sillness and
Loe, 1964) and sulcus bleeding index ≤1 (Mühlemann & Son, 1971). All these criteria
were determined after phase I conventional periodontal therapy.

- Systemically healthy as evidenced by burket's oral medicine health history question
questionnaire (Glick et al., 2008).

- Patients available during follow-up periods

Exclusion Criteria:

- Smoking

- Patient unwilling to comply with periodontal hygienic instructions

- Patients under any long-term chronic medication

- Vulnerable individuals